
---
title: "BiMediX: Bilingual Medical Mixture of Experts LLM"
id: "2402.13253v1"
description: "Introducing BiMediX: bilingual medical LLM for English and Arabic, outperforming state-of-the-art models."
author: Sara Pieri, Sahal Shaji Mullappilly, Fahad Shahbaz Khan, Rao Muhammad Anwer, Salman Khan, Timothy Baldwin, Hisham Cholakkal
date: "2024-02-20"
image: "https://browse.arxiv.org/html/2402.13253v1/x2.png"
categories: ['social-sciences', 'architectures', 'production']
format:
  html:
    code-overflow: wrap
---

![](https://browse.arxiv.org/html/2402.13253v1/x2.png)

### **Summary:**
- BiMediX is a bilingual medical mixture of experts LLM designed for seamless interaction in both English and Arabic.
- The model facilitates a wide range of medical interactions, including multi-turn chats, multiple-choice question answering, and open-ended question answering.
- BiMediX outperforms state-of-the-art Med42 and Meditron by average absolute gains of 2.5% and 4.1%, respectively, in English medical evaluation benchmarks, while operating at 8-times faster inference.
- The model also surpasses the generic Arabic-English bilingual LLM, Jais-30B, by average absolute gains of 10% on Arabic medical benchmarks and 15% on bilingual evaluations across multiple datasets.

### Major Findings:
1. BiMediX is the first bilingual medical mixture of experts LLM with seamless interaction capabilities in both English and Arabic.
2. The model outperforms state-of-the-art medical LLMs in English and Arabic medical benchmarks, achieving significant gains in accuracy and speed.
3. The introduction of BiMed1.3M, an extensive Arabic-English bilingual instruction set, contributes to the model's superior performance in medical evaluations.

### Analysis and Critique:
- The study demonstrates the effectiveness of BiMediX in addressing the challenges of bilingual medical interactions, but it acknowledges potential limitations such as hallucinations, toxicity, and stereotypes inherent in language models.
- The authors emphasize the need for further research to ensure safety and accuracy in clinical settings and to prevent patient harm.
- The release of the model for research purposes underscores the importance of ethical considerations and transparency in the development and deployment of AI technologies in healthcare.

## Appendix

|          |          |
|----------|----------|
| Model     | gpt-3.5-turbo-1106       |
| Date Generated     | 2024-02-26       |
| Abstract | [https://arxiv.org/abs/2402.13253v1](https://arxiv.org/abs/2402.13253v1)        |
| HTML     | [https://browse.arxiv.org/html/2402.13253v1](https://browse.arxiv.org/html/2402.13253v1)       |
| Truncated       | False       |
| Word Count       | 6865       |